Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print RSS Feed

Breaking News

September 30, 2013
Oncology molecule moves to Phase I trials  Read More »
September 30, 2013
Expands nanoscale solutions  Read More »
September 30, 2013
Will supply product for Phase I trials  Read More »
Gil Roth
September 27, 2013
CSL Behring, Durata, Novartis, Zalicus  Read More »
September 27, 2013
Inspection examines overall lab management and procedures  Read More »
September 27, 2013
Will use platform for the discovery and optimization of antibodies  Read More »
September 27, 2013
Crowley to provide strategic guidance to the finance groups  Read More »
September 27, 2013
Direct Detect and Muse Products gain national recognition  Read More »
September 27, 2013
Will analyze mutations and genetic variants in breast cancer  Read More »
Gil Roth
September 26, 2013
Dompe, Exelixis, Lilly, Lumena, NovaRx, ProMetic, Sarepta,   Read More »
September 26, 2013
Amerigen to manufacture generic mecobalamin at Suzhou facility  Read More »
September 26, 2013
To develop and commercialize neurotoxin products  Read More »
September 26, 2013
Creates dedicated discovery unit at Ablynx to develop nanobodies  Read More »
September 26, 2013
Sgherza brings 24 years of pharma, biopharma and CRO expertise   Read More »
September 26, 2013
Offers integrated solution for poorly soluble drugs  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On